Digital tools are becoming increasingly important across veterinary medicine, from clinical workflows to client communication and practice operations.
According to the announcement, IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test. The development is relevant because it reflects how animal health companies, service providers, and technology platforms are responding to changing expectations in veterinary care.
What Was Announced
The test measures a well-established biomarker used to evaluate heart disease in companion animals, a condition that affects approximately 1 in 6 cats 1 and 1 in 10 dogs 2, yet remains underassessed in general practice. At the same time, Catalyst proBNP expands access to a global cardiac testing opportunity estimated at approximately $4 billion 3 while giving veterinarians a practical new tool to assess cardiac health.
The Catalyst proBNP Test helps identify subclinical heart disease in cats, support preoperative evaluations, and evaluate the likelihood of clinically relevant cardiac changes in healthy small- and medium-breed dogs presenting with a heart murmur. In both species, the test helps differentiate cardiac from noncardiac causes of respiratory distress and identify patients who may benefit from closer monitoring, treatment, or specialist referral.
Why This Matters for Veterinary Professionals
For veterinary professionals, technology announcements matter when they affect efficiency, access to care, diagnostics, reimbursement, or the daily workflow of the clinic.
At the practice level, the most relevant question is whether the development can reduce administrative friction, improve access to information, or support more consistent communication between veterinary teams and clients.
Industry Perspective
The animal health industry continues to move toward more connected, data-driven services for veterinary practices and pet owners.
While individual announcements should be interpreted in the context of their source, they can help veterinary professionals monitor where investment, innovation, and market attention are moving across the animal health sector.
Original announcement: IDEXX — https://ir.idexx.com/news-events/press-releases/detail/415/idexx-expands-catalyst-platform-into-cardiac-disease-with-first-and-only-dual-species-point-of-care-nt-probnp-test
Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.